Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma
Open Access
- 1 March 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (10), 7766-7775
- https://doi.org/10.1074/jbc.m105902200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Activation-induced cell deathCurrent Opinion in Immunology, 2001
- B7-1 and B7-2 Have Overlapping, Critical Roles in Immunoglobulin Class Switching and Germinal Center FormationImmunity, 1997
- CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.The Journal of Experimental Medicine, 1995
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994
- Immunoglobulin fold characteristics of B7–1 (CD80) and B7–2 (CD86)Protein Science, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Antibodies to Murine CD40 Stimulate Normal B Lymphocytes but Inhibit Proliferation of B Lymphoma CellsCellular Immunology, 1993
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989